About Altimmune Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a ...

The PhRMA Foundation announced the appointment to its Board of Directors of Dr. John C. Reed, MD, PhD, Executive Vice President of Innovative Medicine R&D at Johnson & Johnson (J&J), and Dr. Donatello ...

He previously served on the Board of Kadmon Holdings, Inc. (NYSE: KDMN), where he was a member of the Transaction Committee involved in overseeing its sale to Sanofi, as well as Immunomedics ...

Christopher is also a Sanofi board member and a member of the Strategy Committee. Since April 2011, he has also been the Chairman of Genzyme. In 2011, net sales reached €33,389 million ...

Ms. Fensterstock previously served as CEO and board member of Lansdowne Labs ... and has held senior management positions at ...

Net sales down 10.0% to €911.9 million, driven by lower volumes for Sanofi and the suspension of production at Brindisi, only ...

Health board members were not aware of Argon Investments' existence nor the checks issued to the LLC. Huacuz caused the ...

Among racial and ethnic groups, non-Hispanic white adults reported the highest rate of seasonal allergies (28.4%), followed ...

Valbiotis unveils its annual financial statements and confirms its strategic and financial goals VALBIOTIS SA VALBIOTIS SA: Valbiotis unveils its annual financial statements and confirms ...

A former Taney County Health Department official pleaded guilty to a scheme to embezzle approximately $260,000 from the ...

Health board members were not aware of the existence of ... Huacuz caused these checks to be coded as payments to Sanofi Pasteur, Inc., a multinational pharmaceutical company.